Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

Patient self-testing for management of anticoagulation therapy: challenges

Author: Mark W. Wurster

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Excerpt

The concept of allowing patients to perform their own INR as part of anticoagulation therapy is not new. Of various methodologies being developed to administer oral anticoagulation, patient self-testing (PST) has perhaps the greatest untapped potential. Numerous challenges in terms of economic, medical-legal, and quality issues have thus far prevented wide spread use of PST in the United States. Potential approaches to expanding the use of PST in this country must successfully address these factors. …
Literature
1.
Ansell J, Jacobson A, Levy J, Voller H, Hasenkam JM (2005) Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 99:37–45PubMedCrossRef
2.
Wittkowsky AK, Sekreta CM, Nutescu EA, Ansell J (2005) Barriers to patient self-testing of prothrombin time; national survey of anticoagulation practitioners. Pharmacotherapy 25(2):265–269PubMedCrossRef
3.
Tripodi A, Bressi C, Carpenedo M, Chantarangkul V, Clerici M, Mannucci PM (2004) Quality assurance program for whole blood prothrombin time- international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation. Thromb Res 113(1):35–40PubMedCrossRef
4.
CoagClinic application, copyright Standing Stone Inc. 1997
Metadata
Title
Patient self-testing for management of anticoagulation therapy: challenges
Author
Mark W. Wurster
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0097-6

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue

OriginalPaper

Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage

Events

Efficacy and safety of warfarin management in US anticoagulation clinic

Events

An observational evaluation of inpatient warfarin utilization and management

Events

Comparison of patient outcomes among Alaska native people using a warfarin dosing algorithm versus patient management system software

Events

Utilization of vitamin K in an outpatient anticoagulation clinic

Events

Optimal dose adjustment in orthopedic patients beginning warfarin therapy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits